Exposure to tobacco smoke in Utero and subsequent plasma lipids, ApoB, and CRP among adult women in the MoBa cohort

Environmental Health Perspectives

Volumn 120, Issue 11, 2012, Pages 1532-1537

  Cupul Uicab, Lea A ^a   Skjaerven, Rolv ^b,c   Haug, Kjell ^b   Travlos, Gregory S ^a   Wilson, Ralph E ^a   Eggesbø, Merete ^c   Hoppin, Jane A ^a   Whitworth, Kristina W ^a   Longnecker, Matthew P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

C reactive protein; Clinical chemistry; Metabolic syndrome; Plasma lipids; Prenatal exposure delayed effects; Smoking; Women

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TOBACCO SMOKE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; INCOME; MATERNAL SMOKING; METABOLIC SYNDROME X; PARITY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; LIPIDS; METABOLIC SYNDROME X; NORWAY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 84868579645     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104563     Document Type: Article

References (38)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, DonatoKA, et al. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640-1645.
2. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298(3):309-316.
3. Bruin JE, Gerstein HC, Holloway AC. 2010. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci 116(2):364-374.
4. Chelchowska M, Ambroszkiewicz J, Gajewska J, Laskowska-Klita T, Leibschang J. 2011. The effect of tobacco smoking during pregnancy on plasma oxidant and antioxidant status in mother and newborn. Eur J Obstet Gynecol Reprod Biol 155(2):132-136.
5. Cole SR, Hernan MA. 2002. Fallibility in estimating direct effects. Int J Epidemiol 31(1):163-165.
6. Cupul-Uicab LA, Baird DD, Skjaerven R, Saha-Chaudhuri P, Haug K, Longnecker MP. 2011a. In utero exposure to maternal smoking and women's risk of fetal loss in the Norwegian Mother and Child Cohort (MoBa). Hum Reprod 26(2):458-465.
7. Cupul-Uicab LA, Skjaerven R, Haug K, Melve KK, Engel SM, Longnecker MP. 2012. In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa Cohort. Environ Health Perspect 120:355-360.
8. Cupul-Uicab LA, Ye X, Skjaerven R, Haug K, Longnecker MP. 2011b. Reproducibility of reported in utero exposure to tobacco smoke. Ann epidemiol 21(1):48-52.
9. Donovan SJ, Susser E. 2011. Commentary: advent of sibling designs. Int J Epidemiol 40(2):345-349.
10. Geerts CC, Bots ML, Grobbee DE, Uiterwaal CS. 2008. Parental smoking and vascular damage in young adult offspring: is early life exposure critical? The Atherosclerosis Risk in Young Adults Study. Arterioscler Thromb Vasc Biol 28(12):2296-2302.
11. Gluckman PD, Hanson MA. 2004. The developmental origins of the metabolic syndrome. Trends Endocrino Metab 15(4):183-187.
12. Greenland S. 1989. Modeling and variable selection in epidemiologic analysis. Am J Public Health 79(3):340-349.
13. Greenland S, Pearl J, Robins JM. 1999. Causal diagrams for epidemiologic research. Epidemiology 10(1):37-48.
14. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109(3):433-438.
15. Horta BL, Gigante DP, Nazmi A, Silveira VM, Oliveira I, Victora CG. 2011. Maternal smoking during pregnancy and risk factors for cardiovascular disease in adulthood. Atherosclerosis 219(2):815-820.
16. Hosmer DW, Lemeshow S. 1992. Confidence interval estimation of interaction. Epidemiology 3(5):452-456.
17. Huang RC, Burke V, Newnham JP, Stanley FJ, Kendall GE, Landau LI, et al. 2007. Perinatal and childhood origins of cardiovascular disease. Int J Obes 31(2):236-244.
18. Hunt KJ, Hansis-Diarte A, Shipman K, Korte JE, Fowler SP, Stern MP. 2006. Impact of parental smoking on diabetes, hypertension and the metabolic syndrome in adult men and women in the San Antonio Heart Study. Diabetologia 49(10):2291-2298.
19. Jaddoe VW, de Ridder MA, van den Elzen AP, Hofman A, Uiterwaal CS, Witteman JC. 2008. Maternal smoking in pregnancy is associated with cholesterol development in the offspring: a 27-years follow-up study. Atherosclerosis 196(1):42-48.
20. Kahn R, Buse J, Ferrannini E, Stern M. 2005. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9):2289-2304.
21. Klajnbard A, Szecsi PB, Colov NP, Andersen MR, Jorgensen M, Bjorngaard B, et al. 2010. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med 48(2):237-248.
22. Kramer MS. 1987. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 65(5):663-737.
23. Kupper LL, McMichael AJ, Spirtas R. 1975. A hybrid epidemiological study design useful in estimating relative risk. J Am Stat Assoc 70(351):524-528.
24. Larsson A, Palm M, Hansson LO, Axelsson O. 2008. Reference values for clinical chemistry tests during normal pregnancy. BJOG 115(7):874-881.
25. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, StoltenbergC. 2006. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 35(5):1146-1150.
26. Metsios GS, Flouris AD, Angioi M, Koutedakis Y. 2011. Passive smoking and the development of cardiovascular disease in children: a systematic review. Cardiol Res Pract 2011:587650; doi:10.4061/2011/587650 [Online 29 August 2010].
27. NCEP (National Cholesterol Education Program). 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285(19):2486-2497.
28. Norman RJ, Dewailly D, Legro RS, Hickey TE. 2007. Polycystic ovary syndrome. Lancet 370(9588):685-697.
29. Norwegian Institute of Public Health. 2007. Norwegian Mother and Child Cohort Study (MoBa). Available: http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_5811&MainArea_5811=5895:0:15,3046:1:0:0:::0:0 [accessed 6June 2011].
30. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. 2005. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 162(11):1108-1113.
31. Power C, Atherton K, Thomas C. 2010. Maternal smoking in pregnancy, adult adiposity and other risk factors for cardiovascular disease. Atherosclerosis 211(2):643-648.
32. Richardson DB, Rzehak P, Klenk J, Weiland SK. 2007. Analyses of case-control data for additional outcomes. Epidemiology 18(4):441-445.
33. Ronningen KS, Paltiel L, Meltzer HM, Nordhagen R, Lie KK, Hovengen R, et al. 2006. The biobank of the Norwegian Mother and Child Cohort Study: a resource for the next 100 years. Eur J Epidemiol 21(8):619-625.
34. Simard JF, Rosner BA, Michels KB. 2008. Exposure to cigarette smoke inutero: comparison of reports from mother and daughter. Epidemiology 19(4):628-633.
35. Vahratian A, Misra VK, Trudeau S, Misra DP. 2010. Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol 116(1):107-113.
36. van Buuren S, Boshuizen HC, Knook DL. 1999. Multiple imputation of missing blood pressure covariates in survival analysis. Statist Med 18(6):681-694.
37. Wen X, Triche EW, Hogan JW, Shenassa ED, Buka SL. 2010. Birth weight and adult hypercholesterolemia: subgroups of small-for-gestational-age based on maternal smoking status during pregnancy. Epidemiology 21(6):786-790.
38. Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, et al. 2012. Perfluorinated compounds and sub-fecundity in pregnant women. Epidemiology 23(2):257-263.